skip to main content

RA CV Risk Magnitude — SCE Rheumatology MCQ

Instant feedback + full explanation. One question, done properly.

HardRheumatoid ArthritisRA CV Risk MagnitudeSCE Rheumatology

A 52-year-old with RA has newly controlled inflammation after a major treatment change. The cardiovascular calculator used locally does not include RA. When should lipids and risk be assessed, and how should the estimate be adjusted?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: C — Assess when stable and 5-yearly; repeat after major treatment changes and apply 1.5

Explanation lettering: C = shown as A · A = shown as C

A is correct. EULAR recommends cardiovascular-risk assessment at least every 5 years and after major antirheumatic treatment changes, with lipids measured when disease is stable; if the chosen model does not already account for RA, a 1.5 multiplier is applied. B uses inflammation-distorted lipids and underestimates risk. C reverses the adjustment. D delays prevention. E replaces population risk assessment with unnecessary universal imaging.

Reference: EULAR cardiovascular-risk recommendations for inflammatory joint disorders: https://ard.bmj.com/content/76/1/17